Australia is closely watching the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist , representing a significant advance in weight loss . Early study data have demonstrated impressive results, https://bikegiantbicycles758757.empirewiki.com/10136964/new_treatment_in_australia_a_potential_solution_for_reducing_body_weight